Filter By Industry
Filter By Tag

Newsroom

Mary Ann Liebert, Inc., publishers Press releases

1 - 10 of 131 Press Releases

Sep 08, 2014
Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com New Genomic Editing Methods Produce Better Disease Models From Patient-Derived Induced Pluripotent Stem Cells New Rochelle, NY—Highly valuable for modeling human...

Sep 03, 2014
Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com Pioneer Award Recipients Robin Ali, PhD, Jean Bennett, MD, PhD, and William Hauswirth, PhD Honored for Their Research on Gene Therapy in Eye Disorders New Rochelle,...

Aug 21, 2014
Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com Conclusive Evidence on Role of Circulating Mesenchymal Stem Cells in Organ Injury Presented in Stem Cells and Development New Rochelle, NY--Mesenchymal stem cells (MSCs)..

Jul 24, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com Malcolm K. Brenner, MD, PhD Receives Pioneer Award for Advances in Gene-Modified T Cells Targeting Cancer New Rochelle, NY—Malcolm K.

Jul 23, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com New Method for Significantly Reducing Tumorigenicity in Induced Pluripotent Stem-Cell Based Therapies New Rochelle, NY, July 23, 2014 – The potential for clinical...

Jul 22, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Novel Methods May Help Stem Cells Survive Transplantation into Damaged Tissues New Rochelle, NY—Stem cells offer much promise for treating damaged organs and...

Jul 21, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com New Research from Africa on Pharmacomicrobiomics New Rochelle, NY—The Human Microbiome Project (HMP) is a global initiative to identify and characterize the...

Jul 17, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...

Jul 16, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com NIH Turns to Crowdsourcing to Repurpose Drugs: Initial Success Exceeds Expectations New Rochelle, NY–Experimental drugs proven safe but perhaps not sufficiently...

Jul 15, 2014
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Genetic Testing for Alcohol Dependence Risk in African Americans New Rochelle, NY—Alcohol dependence (AD) has a genetic component and testing can determine a...


Page: 1 2 3 4 5 Next
Mary Ann Liebert, Inc., publishers RSS Feed